January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

In this video, Sham Mailankody, MBBS discusses the current state of the pipeline for developing multiple myeloma treatments.

Bispecific antibodies are novel molecules where two antigens can be targeted at the same ... tumor necrosis factor; Tregs, regulatory T cells; Trikes, trispecific killer cell engagers.

Learn more about whether Biogen Inc. or Gilead Sciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

As the U.S. stock market continues to rally following President Trump's return to office, investors are closely watching the impact of new policies on various sectors. In this context, penny ...

A bispecific (and trispecific) educative horizon What elranatamab offers, by comparison, is a bispecific antibody that is off-the-shelf. “It’s developed and delivered to a hospital pharmacy in ...

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a ...